UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Bridge Biotherapeutics passes preliminary review for Kosdaq listing
by Jeong Sae-im
2019-10-25 15:05
KangStem Biotech fails in phase-3 study on atopic dermatitis drug
by Jeong Sae-im
2019-10-25 11:17
Value assessment on anticancer drugs hotly discussed
by Jeong Sae-im
2019-10-24 13:46
PharmAbcine sets up US unit to develop anticancer drug
by Jeong Sae-im
2019-10-23 15:48
‘Oral drugs as effective as inhalers for elderly with asthma’
by Jeong Sae-im
2019-10-22 15:48
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
by Jeong Sae-im
2019-10-21 16:42
Drug firms’ Q3 earnings to be fairly good
by Jeong Sae-im
2019-10-21 12:27
Medytox exported ₩3.3 billion worth of unqualified BTX
by Jeong Sae-im
2019-10-18 16:02
US sales of Remicade drop due to biosimilar’s rise
by Jeong Sae-im
2019-10-17 13:32
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
by Jeong Sae-im
2019-10-16 14:16
라인
Kolon Life Science shares surge after TissueGene’s survival
by Jeong Sae-im
2019-10-14 18:01
HLB merges with Elevar to own rivoceranib rights
by Jeong Sae-im
2019-10-14 14:43
‘Kosdaq firms listed for exceptional tech need special monitoring’
by Jeong Sae-im
2019-10-07 15:51
Samsung execs pass buck to biotech subsidiaries for destroying evidence
by Jeong Sae-im
2019-10-04 11:42
Regulator raids cell therapy makers too often to little avail
by Jeong Sae-im
2019-10-02 11:23
라인
Will parliamentary audit uncover why Invossa was mislabeled?
by Jeong Sae-im
2019-10-01 15:45
Ranitidine recall taking heavy toll on pharmaceuticals
by Jeong Sae-im
2019-09-30 15:16
Regulator explained why it banned stomach medicine ranitidine altogether
by Jeong Sae-im
2019-09-27 15:02
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’
by Jeong Sae-im
2019-09-26 15:24
Helixmith blames hospital for absurd drug mix-up
by Jeong Sae-im
2019-09-25 13:42
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top